These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 11308032
21. STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Wang IM, Lin H, Goldman SJ, Kobayashi M. Mol Immunol; 2004 Jul; 41(9):873-84. PubMed ID: 15261459 [Abstract] [Full Text] [Related]
22. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis. Yamada K, Ariyoshi K, Onishi M, Miyajima A, Hayakawa F, Towatari M, Saito H, Oka Y, Asano S, Nosaka T, Kitamura T. Int J Hematol; 2000 Jan; 71(1):46-54. PubMed ID: 10729993 [Abstract] [Full Text] [Related]
23. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. Kazansky AV, Rosen JM. Cell Growth Differ; 2001 Jan; 12(1):1-7. PubMed ID: 11205741 [Abstract] [Full Text] [Related]
24. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome. Mitchell TJ, Whittaker SJ, John S. Cancer Res; 2003 Dec 15; 63(24):9048-54. PubMed ID: 14695224 [Abstract] [Full Text] [Related]
25. Transcriptional regulation of SLP-76 family hematopoietic cell adaptor MIST/Clnk by STAT5. Sasanuma H, Tatsuno A, Tsuji K, Hidano S, Morita S, Kitamura T, Kubo M, Kitamura D, Goitsuka R. Biochem Biophys Res Commun; 2004 Aug 13; 321(1):145-53. PubMed ID: 15358227 [Abstract] [Full Text] [Related]
27. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. Ohmori Y, Smith MF, Hamilton TA. J Immunol; 1996 Sep 01; 157(5):2058-65. PubMed ID: 8757327 [Abstract] [Full Text] [Related]
28. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. Ryan JJ, McReynolds LJ, Huang H, Nelms K, Paul WE. J Immunol; 1998 Aug 15; 161(4):1811-21. PubMed ID: 9712048 [Abstract] [Full Text] [Related]
29. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells. Hoover RR, Gerlach MJ, Koh EY, Daley GQ. Oncogene; 2001 Sep 13; 20(41):5826-35. PubMed ID: 11593388 [Abstract] [Full Text] [Related]
30. Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas. Abraham N, Ma MC, Snow JW, Miners MJ, Herndier BG, Goldsmith MA. Oncogene; 2005 Aug 04; 24(33):5252-7. PubMed ID: 15870688 [Abstract] [Full Text] [Related]
31. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites. Imbert V, Rezzonico R, Reichenbach P, Nabholz M. Eur Cytokine Netw; 2002 Aug 04; 13(3):331-9. PubMed ID: 12231477 [Abstract] [Full Text] [Related]
32. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma. Shipley JM, Waxman DJ. Mol Pharmacol; 2003 Aug 04; 64(2):355-64. PubMed ID: 12869640 [Abstract] [Full Text] [Related]
33. Functional roles of STAT family proteins: lessons from knockout mice. Akira S. Stem Cells; 1999 Aug 04; 17(3):138-46. PubMed ID: 10342556 [Abstract] [Full Text] [Related]
34. Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation. Dentelli P, Del Sorbo L, Rosso A, Molinar A, Garbarino G, Camussi G, Pegoraro L, Brizzi MF. J Immunol; 1999 Aug 15; 163(4):2151-9. PubMed ID: 10438956 [Abstract] [Full Text] [Related]
35. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation. Friedrich K, Kammer W, Erhardt I, Brändlein S, Sebald W, Moriggl R. Int Immunol; 1999 Aug 15; 11(8):1283-94. PubMed ID: 10421786 [Abstract] [Full Text] [Related]
36. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain. Lischke A, Moriggl R, Brändlein S, Berchtold S, Kammer W, Sebald W, Groner B, Liu X, Hennighausen L, Friedrich K. J Biol Chem; 1998 Nov 20; 273(47):31222-9. PubMed ID: 9813029 [Abstract] [Full Text] [Related]
37. IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway. Aronica MA, Goenka S, Boothby M. Cytokine; 2000 Jun 20; 12(6):578-87. PubMed ID: 10843732 [Abstract] [Full Text] [Related]
38. Activation of STAT proteins and growth control. Bromberg JF. Bioessays; 2001 Feb 20; 23(2):161-9. PubMed ID: 11169589 [Abstract] [Full Text] [Related]
39. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Friedrichsen BN, Richter HE, Hansen JA, Rhodes CJ, Nielsen JH, Billestrup N, Møldrup A. Mol Endocrinol; 2003 May 20; 17(5):945-58. PubMed ID: 12586844 [Abstract] [Full Text] [Related]
40. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells. Demoulin JB, Uyttenhove C, Lejeune D, Mui A, Groner B, Renauld JC. Cancer Res; 2000 Jul 15; 60(14):3971-7. PubMed ID: 10919676 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]